NCT06231316

Brief Summary

Examining the advantages associated with the utilization of noradrenaline in preventing spinal hypotension during cesarean births. This involves assessing the positive outcomes and potential benefits derived from incorporating noradrenaline into the medical approach.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

1 year

First QC Date

January 20, 2024

Last Update Submit

January 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The frequency of postspinal hypotension

    Assessment of how often blood pressure decreases following spinal anesthesia, crucial for proactive management in medical procedures.

    baseline

Secondary Outcomes (1)

  • Hemodynamic data

    baseline

Interventions

Norepinephrine is both a neurotransmitter and a hormone. It is essential vasopressor for rapid blood pressure support, crucial in maintaining hemodynamic stability

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Sample size was calculated using Epi- Info7. Based on Frequency of spinal hypotension decrease to 20% in patients received0.5\_.10mg epinephrine ( put ref . ). With a confidence limits 5% and a confidence level of 90% the minimum patients required for this study is 173cases

You may qualify if:

  • The subject is scheduled for elective cesarean section .
  • No obvious abnormalities in preoperative ECG, blood routine, electrolytes, and other tests.
  • ASA class 1-3.

You may not qualify if:

  • Patients have body mass index (BMI) \>35 kg/m2. -Patients are known hypersensitivity to any of the drugs that would be used in the study. -
  • Severe cardiac, renal, lung, or liver diseases.
  • Eclampsia or preexisting hypertension (baseline systolic blood pressure ≥160 mmHg)
  • hemoglobin \<7 g/dL, or fetal distress.
  • Patients that are immunologically compromised.
  • Sleep apnea syndrome or difficult airway. 8.preexisting hypoxemia (Spo2\< 90 %).
  • Patient refusal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015 Apr;122(4):736-45. doi: 10.1097/ALN.0000000000000601.

    PMID: 25635593BACKGROUND
  • Ngan Kee WD, Lee SWY, Ng FF, Khaw KS. Prophylactic Norepinephrine Infusion for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery. Anesth Analg. 2018 Jun;126(6):1989-1994. doi: 10.1213/ANE.0000000000002243.

    PMID: 28678073BACKGROUND
  • Sakata K, Yoshimura N, Tanabe K, Kito K, Nagase K, Iida H. Prediction of hypotension during spinal anesthesia for elective cesarean section by altered heart rate variability induced by postural change. Int J Obstet Anesth. 2017 Feb;29:34-38. doi: 10.1016/j.ijoa.2016.09.004. Epub 2016 Sep 22.

    PMID: 27789074BACKGROUND
  • Kuhn JC, Hauge TH, Rosseland LA, Dahl V, Langesaeter E. Hemodynamics of Phenylephrine Infusion Versus Lower Extremity Compression During Spinal Anesthesia for Cesarean Delivery: A Randomized, Double-Blind, Placebo-Controlled Study. Anesth Analg. 2016 Apr;122(4):1120-9. doi: 10.1213/ANE.0000000000001174.

    PMID: 26991619BACKGROUND
  • Macarthur A, Riley ET. Obstetric anesthesia controversies: vasopressor choice for postspinal hypotension during cesarean delivery. Int Anesthesiol Clin. 2007 Winter;45(1):115-32. doi: 10.1097/AIA.0b013e31802b8d53. No abstract available.

    PMID: 17215703BACKGROUND
  • Lee JE, George RB, Habib AS. Spinal-induced hypotension: Incidence, mechanisms, prophylaxis, and management: Summarizing 20 years of research. Best Pract Res Clin Anaesthesiol. 2017 Mar;31(1):57-68. doi: 10.1016/j.bpa.2017.01.001. Epub 2017 Jan 8.

    PMID: 28625306BACKGROUND
  • Fitzgerald JP, Fedoruk KA, Jadin SM, Carvalho B, Halpern SH. Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia. 2020 Jan;75(1):109-121. doi: 10.1111/anae.14841. Epub 2019 Sep 18.

    PMID: 31531852BACKGROUND

MeSH Terms

Interventions

Norepinephrine

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

January 20, 2024

First Posted

January 30, 2024

Study Start

March 1, 2024

Primary Completion

March 1, 2025

Study Completion

May 1, 2025

Last Updated

January 30, 2024

Record last verified: 2024-01